71441-11-7Relevant academic research and scientific papers
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
-
, (2015/12/30)
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce such molecules and intermediates used in such processes, compositions containing such molecules, and processes of using such molecules against such pests. These molecules may be used, for example, as nematicides, acaricides, insecticides, miticides, and/or molluscicides. This document discloses molecules having the following formula (“Formula One”).
Pesticidal compositions and processes related thereto
-
, (2016/01/09)
This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
-
, (2014/06/25)
This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
-
, (2014/06/25)
This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
-
, (2014/07/08)
This document discloses molecules having the following formula ("Formula One") and processes associated therewith.
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
-
, (2014/07/08)
This document discloses molecules having the following formula ("Formula One"): and processes associated therewith.
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
-
, (2014/06/25)
This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
-
, (2013/02/28)
This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.
Synthesis of novel heteroarotinoids with receptor activation capabilities and tgase activity. Single crystal analysis of (E)-4-[(2,3-dihydro-2,2,4,4,- tetramethyl-2H-1-benzo-[b]thiopyran-6-Yl)-1-propenyl]-2-methylbenzoic acid
Subramanian, Shunkar,Smith, Chad M.,Tabatabai, Ali,Bryan, Clinton D.,Buettner, Brian,Hale, Steve,Wakefield, Cynthia A.,Benbrook, Doris M.,Berlin, K. Darrell
, p. 67 - 77 (2007/10/03)
The syntheses of ethyl (E)-4-[(2,3-dihydro-2,2,4,4-tetramethyl-2H-1- benzo[b]-thiopyran-6-yl)-1-propenyl]-2-methylbenzoate (1) and (E)-4- [(2,3-dihydro-2,2,4,4-tetramethyl-2H-1-benzo[b]thiopyran-6-yl)-1-pro- penyl]-2-methylbenzoic acid (2) have been achieved. In comparison to ester 1, acid 2 exhibited greater efficacy in activating RARα, RARβ, and RARγ as well as greater potency in activating RARα and RARβ. Interestingly, both the ester 1 and acid 2 exhibited nearly equal potency in activating RARγ. Both compounds also induced tissue transglutaminase (TGase) activity approximately 50% of the level induced by trans-retinoic acid. An X-ray diffraction analysis of (E)-2 revealed the aryl rings as nearly orthogonal [74.0(2)°] and a torsional angle of 46.5(2)° between the thiochroman group and the propenyl group. Conjugation between such groups may not be a stringent requirement for receptor activation. Copyright Taylor & Francis Inc.
Stilbene derivatives
-
, (2008/06/13)
This invention is directed to 5,6,7,8-tetrahydro-naphthyl or indanyl stilbene derivatives which are useful as tumor inhibiting agents, in the treatment of neoplasms, dermatological conditions and rheumatic illnesses.
